Drugs and diseases: Summary and consensus statements of group 1. The 5th EAO Consensus Conference 2018
| Autor: | Henning Schliephake, Alberto Sicilia, Bilal Al Nawas, Nikos Donos, Reinhard Gruber, Søren Jepsen, Iva Milinkovic, Andrea Mombelli, Jose Manuel Navarro, Marc Quirynen, Isabella Rocchietta, Morten Schiødt, Søren Schou, Alexandra Stähli, Andreas Stavropoulos, Luis Miguel Sánchez Suárez |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Technology medicine.medical_specialty medication-related osteonecrosis of the jaws platelet-rich fibrin 610 Medicine & health Odontologi 03 medical and health sciences Engineering 0302 clinical medicine systematic review guided bone regeneration sinus floor elevation dental implants Dentistry Oral Surgery & Medicine medicine antiresorptive drugs titanium Engineering Biomedical bisphosphonates Science & Technology corrosion business.industry Consensus conference implant therapy platelet-rich plasma 030206 dentistry ddc:617.6 3. Good health hormone replacement therapy Antiresorptive Drugs 030104 developmental biology Systematic review Group analysis Dentistry Family medicine alveolar ridge preservation Oral Surgery business Life Sciences & Biomedicine peri-implantitis |
| Zdroj: | Clinical Oral Implants Research, Vol. 29 (2018) pp. 93-99 Schliephake, Henning; Sicilia, Alberto; Nawas, Bilal Al; Donos, Nikos; Gruber, Reinhard; Jepsen, Søren; Milinkovic, Iva; Mombelli, Andrea; Navarro, Jose Manuel; Quirynen, Marc; Rocchietta, Isabella; Schiødt, Morten; Schou, Søren; Stähli, Alexandra Beatrice; Stavropoulos, Andreas (2018). Drugs and diseases: Summary and consensus statements of group 1. The 5 EAO Consensus Conference 2018. Clinical oral implants research, 29(Suppl. 18), pp. 93-99. Wiley-Blackwell 10.1111/clr.13270 Clinical Oral Implants Research Scopus RUO. Repositorio Institucional de la Universidad de Oviedo instname |
| ISSN: | 0905-7161 |
| DOI: | 10.1111/clr.13270 |
| Popis: | OBJECTIVES: The task of this working group was to update the knowledge about the use of drugs and biologicals affecting healing of soft tissue and bone during implant treatment or procedures associated with it. Moreover, the impact of titanium particles and biocorrosion on complications and implant survival has been analysed. MATERIALS AND METHODS: The literature in the areas of interest (platelet concentrates, antiresorptive drugs as well as implant-host interaction) was screened using systematic reviews for the former two areas, whereas a narrative critical review was performed for the latter topic. Two manuscripts on platelet concentrates, one manuscript on antiresorptive drugs and one manuscript on the effects of biocorrosion, were presented for group analysis with subsequent discussion in the plenum and final consensus approval. RESULTS: Results and conclusions of the individual reviews of the three topics are presented in the respective papers. Conclusions of the group on strengths and weaknesses of available evidence as well as consensus statements and directions for further research are provided in this study. The following papers were subject to group discussions and formed the basis for the consensus statements: Stähli A, Strauss FJ, Gruber R. () The use of platelet-rich-plasma to enhance the outcomes of implant-related therapies: a systematic review Strauss FJ, Stähli A, Gruber R. (2018) The use of platelet-rich-fibrin to enhance the outcomes of implant-related therapies: a systematic review Mombelli A, Hashim D, Cionca N. () What is the impact of titanium particles and bio-corrosion on implant survival and complications? A critical review Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Morten Schiødt, Klinge B. () The effect of antiresorptive drugs on implant therapy: a systematic review. ispartof: CLINICAL ORAL IMPLANTS RESEARCH vol:29 pages:93-99 ispartof: location:SWITZERLAND, Pfaffikon status: published |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text